165 related articles for article (PubMed ID: 37715273)
1. Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study.
Suzuki S; Asakura K; Okui M; Izawa N; Sawafuji M; Sakamaki H; Shigenobu T; Tajima A; Oka N; Masai K; Kaseda K; Hishida T; Yasuda H; Fukunaga K; Asamura H
World J Surg Oncol; 2023 Sep; 21(1):290. PubMed ID: 37715273
[TBL] [Abstract][Full Text] [Related]
2. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment.
Ohtaki Y; Shimizu K; Suzuki H; Suzuki K; Tsuboi M; Mitsudomi T; Takao M; Murakawa T; Ito H; Yoshimura K; Okada M; Chida M;
Lung Cancer; 2021 Mar; 153():108-116. PubMed ID: 33482408
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
5. Safety and efficacy of salvage surgery for non-small cell lung cancer: a retrospective study of 46 patients from four Keio-affiliated hospitals.
Suzuki S; Asakura K; Okui M; Sawafuji M; Shigenobu T; Tajima A; Kaseda K; Masai K; Hishida T; Asamura H
Gen Thorac Cardiovasc Surg; 2022 Oct; 70(10):891-899. PubMed ID: 35344124
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
7. Salvage surgery for advanced non-small cell lung cancer after targeted therapy: A case series.
Song W; Di S; Liu J; Fan B; Zhao J; Zhou S; Chen S; Dong H; Yue C; Gong T
Thorac Cancer; 2020 Apr; 11(4):1061-1067. PubMed ID: 32107870
[TBL] [Abstract][Full Text] [Related]
8. Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study.
Higuchi M; Inomata S; Yamaguchi H; Saito T; Suzuki H
J Cardiothorac Surg; 2023 Jul; 18(1):235. PubMed ID: 37475037
[TBL] [Abstract][Full Text] [Related]
9. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer.
Sawabata N; Ohta M; Takeda S; Hirano H; Okumura Y; Asada H; Maeda H
Ann Thorac Surg; 2002 Jul; 74(1):174-9. PubMed ID: 12118753
[TBL] [Abstract][Full Text] [Related]
10. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
[TBL] [Abstract][Full Text] [Related]
11. Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
Kuo SW; Chen PH; Lu TP; Chen KC; Liao HC; Tsou KC; Tsai TM; Lin MW; Hsu HH; Chen JS
Ann Surg Oncol; 2022 Aug; 29(8):4873-4884. PubMed ID: 35254583
[TBL] [Abstract][Full Text] [Related]
12. Salvage surgery following downstaging of advanced non-small cell lung cancer by targeted therapy.
Li K; Cao X; Ai B; Xiao H; Huang Q; Zhang Z; Chu Q; Zhang L; Dai X; Liao Y
Thorac Cancer; 2021 Aug; 12(15):2161-2169. PubMed ID: 34128318
[TBL] [Abstract][Full Text] [Related]
13. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer.
Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K
Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Serum CEA Level is a More Significant Prognostic Factor than Post/Preoperative Serum CEA Ratio in Non-small Cell Cancer Patients.
Tomita M; Ayabe T; Chosa E; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(17):7809-12. PubMed ID: 26625802
[TBL] [Abstract][Full Text] [Related]
15. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients.
Jiang W; Pang X; Xi J; Chen X; Wang Q; Qian C; Fan H
J Surg Oncol; 2014 Sep; 110(3):233-8. PubMed ID: 24888753
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
18. Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM; Lai CH; Chang HC; Chao TY; Tseng CC; Fang WF; Wang CC; Chung YH; Huang KT; Chen HC; Chang YC; Lin MC
Medicine (Baltimore); 2015 Dec; 94(50):e2239. PubMed ID: 26683939
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of surgically resected lung cancer with extremely high preoperative serum carcinoembryonic antigen level.
Takahashi N; Suzuki K; Takamochi K; Oh S
Gen Thorac Cardiovasc Surg; 2011 Oct; 59(10):699-704. PubMed ID: 21984138
[TBL] [Abstract][Full Text] [Related]
20. Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.
Arrieta O; Varela-Santoyo E; Cardona AF; Sánchez-Reyes R; Lara-Mejía L; Bassarmal SS; Valle-Bautista D; Corrales-Rodríguez L; Motola-Kuba D; Cabrera-Miranda L; Martín C
Clin Lung Cancer; 2021 Nov; 22(6):510-522. PubMed ID: 33947631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
